Fangyuan Liu

ORCID: 0000-0002-3755-7705 · 6 papers in corpus
review 2026
Clinical epigenetics ·doi:10.1186/s13148-026-02185-y

Lactic acid modification of histones represents an emerging post-translational modification that establishes a critical link between cellular metabolic reprogramming and epigenetic regulation through the covalent binding of lactic acid to h…

review 2026
Frontiers in pharmacology ·doi:10.3389/fphar.2026.1742212

Endometriosis (EMs) is a gynecological inflammatory disease that depends on estrogen. Its chief symptoms include dysmenorrhea, chronic pelvic pain, reduced fertility, and pelvic masses. Although various hormonal therapies and surgical treat…

review 2025
International journal of nanomedicine ·doi:10.2147/ijn.s570068

Among gynecologic malignancies, ovarian cancer (OC) stands out as a highly aggressive disease with the highest mortality rate and the poorest prognosis. At the beginning stage, it demonstrates high sensitivity to platinum-based chemotherapy…

review 2025
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.70046

Endometriosis is a prevalent chronic gynecological disease that poses significant challenges for treatment due to its extensive lesions, diverse morphology, unknown etiology, and tendency for recurrence. In the early 21st century, the stem …

review 2025
Journal of ovarian research ·doi:10.1186/s13048-025-01864-3

Ovarian cancer remains the most lethal malignancy of the female reproductive tract. Because early-stage disease is almost silent, roughly 70% of patients present with advanced, disseminated tumors. The current standard-maximal cytoreductive…

meta-analysis 2024
Frontiers in pharmacology ·doi:10.3389/fphar.2024.1376037

BACKGROUND: Ovarian endometriotic cysts (OEC) represent the primary manifestation of endometriosis, constituting a hormonally dependent inflammatory disorder in gynecology. It significantly affects the quality of life and reproductive healt…